126 related articles for article (PubMed ID: 26514401)
1. Inhibition of kynurenine aminotransferase II reduces activity of midbrain dopamine neurons.
Linderholm KR; Alm MT; Larsson MK; Olsson SK; Goiny M; Hajos M; Erhardt S; Engberg G
Neuropharmacology; 2016 Mar; 102():42-7. PubMed ID: 26514401
[TBL] [Abstract][Full Text] [Related]
2. Activation of rat ventral tegmental area dopamine neurons by endogenous kynurenic acid: a pharmacological analysis.
Linderholm KR; Andersson A; Olsson S; Olsson E; Snodgrass R; Engberg G; Erhardt S
Neuropharmacology; 2007 Dec; 53(8):918-24. PubMed ID: 17959203
[TBL] [Abstract][Full Text] [Related]
3. Effects of COX-1 and COX-2 inhibitors on the firing of rat midbrain dopaminergic neurons--possible involvement of endogenous kynurenic acid.
Schwieler L; Erhardt S; Nilsson L; Linderholm K; Engberg G
Synapse; 2006 Apr; 59(5):290-8. PubMed ID: 16416446
[TBL] [Abstract][Full Text] [Related]
4. Clozapine modulates midbrain dopamine neuron firing via interaction with the NMDA receptor complex.
Schwieler L; Engberg G; Erhardt S
Synapse; 2004 May; 52(2):114-22. PubMed ID: 15034917
[TBL] [Abstract][Full Text] [Related]
5. Increased phasic activity of dopaminergic neurones in the rat ventral tegmental area following pharmacologically elevated levels of endogenous kynurenic acid.
Erhardt S; Engberg G
Acta Physiol Scand; 2002 May; 175(1):45-53. PubMed ID: 11982504
[TBL] [Abstract][Full Text] [Related]
6. Elevated levels of kynurenic acid change the dopaminergic response to amphetamine: implications for schizophrenia.
Olsson SK; Andersson AS; Linderholm KR; Holtze M; Nilsson-Todd LK; Schwieler L; Olsson E; Larsson K; Engberg G; Erhardt S
Int J Neuropsychopharmacol; 2009 May; 12(4):501-12. PubMed ID: 18796185
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory action of clozapine on rat ventral tegmental area dopamine neurons following increased levels of endogenous kynurenic acid.
Schwieler L; Erhardt S
Neuropsychopharmacology; 2003 Oct; 28(10):1770-7. PubMed ID: 12865892
[TBL] [Abstract][Full Text] [Related]
8. GABA(B) receptor-mediated modulation of the firing pattern of ventral tegmental area dopamine neurons in vivo.
Erhardt S; Mathé JM; Chergui K; Engberg G; Svensson TH
Naunyn Schmiedebergs Arch Pharmacol; 2002 Mar; 365(3):173-80. PubMed ID: 11882912
[TBL] [Abstract][Full Text] [Related]
9. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
[TBL] [Abstract][Full Text] [Related]
10. Excitatory and inhibitory responses of dopamine neurons in the ventral tegmental area to nicotine.
Erhardt S; Schwieler L; Engberg G
Synapse; 2002 Mar; 43(4):227-37. PubMed ID: 11835517
[TBL] [Abstract][Full Text] [Related]
11. A systemically-available kynurenine aminotransferase II (KAT II) inhibitor restores nicotine-evoked glutamatergic activity in the cortex of rats.
Koshy Cherian A; Gritton H; Johnson DE; Young D; Kozak R; Sarter M
Neuropharmacology; 2014 Jul; 82():41-8. PubMed ID: 24647121
[TBL] [Abstract][Full Text] [Related]
12. The acute and chronic administration of the 5-HT(2B/2C) receptor antagonist SB-200646A significantly alters the activity of spontaneously active midbrain dopamine neurons in the rat: An in vivo extracellular single cell study.
Blackburn TP; Suzuki K; Ashby CR
Synapse; 2006 Jun; 59(8):502-12. PubMed ID: 16565966
[TBL] [Abstract][Full Text] [Related]
13. Intracerebroventricular administration of NMDA-R1 antisense oligodeoxynucleotide significantly alters the activity of ventral tegmental area dopamine neurons: an electrophysiological study.
Tajiri K; Emori K; Murata M; Tanaka K; Suzuki M; Uehara T; Sumiyoshi T; Ashby CR; Kurachi M
Synapse; 2001 Jun; 40(4):275-81. PubMed ID: 11309843
[TBL] [Abstract][Full Text] [Related]
14. Importance of kynurenine 3-monooxygenase for spontaneous firing and pharmacological responses of midbrain dopamine neurons: Relevance for schizophrenia.
Tufvesson-Alm M; Schwieler L; Schwarcz R; Goiny M; Erhardt S; Engberg G
Neuropharmacology; 2018 Aug; 138():130-139. PubMed ID: 29879409
[TBL] [Abstract][Full Text] [Related]
15. Kynurenic acid leads, dopamine follows: a new case of volume transmission in the brain?
Wu HQ; Rassoulpour A; Schwarcz R
J Neural Transm (Vienna); 2007 Jan; 114(1):33-41. PubMed ID: 16932989
[TBL] [Abstract][Full Text] [Related]
16. Subchronic treatment with kynurenine and probenecid: effects on prepulse inhibition and firing of midbrain dopamine neurons.
Nilsson LK; Linderholm KR; Erhardt S
J Neural Transm (Vienna); 2006 May; 113(5):557-71. PubMed ID: 16082514
[TBL] [Abstract][Full Text] [Related]
17. Effects of antipsychotic treatments and D-serine supplementation on the electrophysiological activation of midbrain dopamine neurons induced by the noncompetitive NMDA antagonist MK 801.
Bennett S; Gronier B
Synapse; 2007 Aug; 61(8):679-88. PubMed ID: 17523181
[TBL] [Abstract][Full Text] [Related]
18. Clozapine interacts with the glycine site of the NMDA receptor: electrophysiological studies of dopamine neurons in the rat ventral tegmental area.
Schwieler L; Linderholm KR; Nilsson-Todd LK; Erhardt S; Engberg G
Life Sci; 2008 Aug; 83(5-6):170-5. PubMed ID: 18590745
[TBL] [Abstract][Full Text] [Related]
19. The acute and chronic administration of (+/-)-8-hydroxy-2-(Di-n-propylamino)tetralin significantly alters the activity of spontaneously active midbrain dopamine neurons in rats: an in vivo electrophysiological study.
Nakamura K; Suzuki K; McCreary AC; Ashby CR
Synapse; 2006 May; 59(6):359-67. PubMed ID: 16463399
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptor membrane dynamics tunes the firing pattern of midbrain dopaminergic neurons.
Etchepare L; Gréa H; Durand P; Bouchet D; Groc L
J Physiol; 2021 Jun; 599(11):2933-2951. PubMed ID: 33651437
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
